Literature DB >> 9337128

NMDA-receptor antagonist protects neurons from secondary degeneration after partial optic nerve crush.

E Yoles1, S Muller, M Schwartz.   

Abstract

Damage resulting from a partial acute lesion of white matter in the central nervous system (CNS) gradually spreads also to neurons that escaped the primary injury, resulting in their degeneration. Such spreading has been referred to as secondary degeneration. In order to demonstrate that this degeneration is indeed secondary to that caused by the acute insult, as well as to investigate the mechanism underlying the spread of damage and ways in which to protect neurons from such damage, we have proposed the use of partial lesion of the rodent optic nerve as a model. In this model we examined whether an antagonist of a receptor-mediated channel, shown to be beneficial in gray matter lesions, can protect neurons from undergoing secondary degeneration following white matter lesion. A well-calibrated partial crush lesion inflicted on the optic nerve of adult rats was immediately followed by a single intraperitoneal injection of the N-methyl-D-aspartate receptor antagonist, MK-801 (1 mg/kg). Protection of neurons from secondary degeneration was assessed by retrograde labeling and by measurement of the visual evoked potential (VEP) response to light. Two weeks after the injury, the mean number of neurons that were still intact was about threefold higher in the MK-801-treated group than in the saline-treated control group, indicating a treatment-induced protection of neurons that had escaped primary injury. A positive VEP response to light was obtained in 90% of the MK-801 treated animals and in only 50% of injured controls. The questions regarding whether the secondary degeneration of initially spared neurons starts in their cell bodies or in their axons, and consequently the identity of the primary site of their protection by MK-801, are discussed in relation to the absence of N-methyl-D-aspartate receptors on nerve fibers. The present findings may have implications for both acute and chronic injuries of the CNS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9337128     DOI: 10.1089/neu.1997.14.665

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  20 in total

1.  Protective autoimmunity is a physiological response to CNS trauma.

Authors:  E Yoles; E Hauben; O Palgi; E Agranov; A Gothilf; A Cohen; V Kuchroo; I R Cohen; H Weiner; M Schwartz
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

2.  The cell and molecular biology of glaucoma: mechanisms of retinal ganglion cell death.

Authors:  Robert W Nickells
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-04       Impact factor: 4.799

Review 3.  BAX to basics: How the BCL2 gene family controls the death of retinal ganglion cells.

Authors:  Margaret E Maes; Cassandra L Schlamp; Robert W Nickells
Journal:  Prog Retin Eye Res       Date:  2017-01-04       Impact factor: 21.198

Review 4.  Pathophysiology of primary open-angle glaucoma from a neuroinflammatory and neurotoxicity perspective: a review of the literature.

Authors:  Karine Evangelho; Maria Mogilevskaya; Monica Losada-Barragan; Jeinny Karina Vargas-Sanchez
Journal:  Int Ophthalmol       Date:  2017-12-30       Impact factor: 2.031

5.  Neuroprotective effects of cardiotrophin-like cytokine on retinal ganglion cells.

Authors:  Frank Schuettauf; David Zurakowski; Kristine Quinto; Meghana A Varde; Dorothea Besch; Alan Laties; Ralph Anderson; Rong Wen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-20       Impact factor: 3.117

6.  A cell-permeable phosphine-borane complex delays retinal ganglion cell death after axonal injury through activation of the pro-survival extracellular signal-regulated kinases 1/2 pathway.

Authors:  Mohammadali Almasieh; Christopher J Lieven; Leonard A Levin; Adriana Di Polo
Journal:  J Neurochem       Date:  2011-08-12       Impact factor: 5.372

7.  Morphological and functional changes of the optic nerve following traumatic optic nerve injuries in rabbits.

Authors:  Fei Xue; Kunming Wu; Tianyou Wang; You Cheng; Manjie Jiang; Junfeng Ji
Journal:  Biomed Rep       Date:  2016-01-07

Review 8.  Harnessing the immune system for neuroprotection: therapeutic vaccines for acute and chronic neurodegenerative disorders.

Authors:  M Schwartz
Journal:  Cell Mol Neurobiol       Date:  2001-12       Impact factor: 5.046

9.  Early decompression of the injured optic nerve reduces axonal degeneration and improves functional outcome in the adult rat.

Authors:  Marcus Ohlsson; Mikael Svensson
Journal:  Exp Brain Res       Date:  2006-11-14       Impact factor: 1.972

Review 10.  Rodent models of glaucoma.

Authors:  Thomas V Johnson; Stanislav I Tomarev
Journal:  Brain Res Bull       Date:  2009-04-18       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.